Irvine Pharmaceutical Services, Inc. will open a new analytical facility in Hangzhou, China. The new 115,000-sq.-ft. facility will expand Irvine’s service offerings into the Asian market and is scheduled to be fully operational in 1Q15.   Chief executive officer and founder, Dr. Assad J. Kazeminy said, ” Irvine is responding to the rising needs of large multi-national pharmaceutical companies that are looking for contract organizations overseas that include robust cGMP quality infras...